HDM1702
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
Huadong Medicine · Phase 3 · Recruiting · Enrollment 460
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| HDM1702 | n/r | n/r | n/r | n/r |
| WEGOVY® | n/r | n/r | n/r | n/r |
Not shown
- HDM1702: endpoint not reported
- WEGOVY®: endpoint not reported